MHC-I–restricted presentation of HIV-1 virion antigens without viral replication
10.1038/85493
Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Buseyne, F., Gall, S. L., Boccaccio, C., Abastado, J.-P., Lifson, J. D., Arthur, L. O., Rivière, Y., Heard, J.-M., & Schwartz, O. (2001). MHC-I–restricted presentation of HIV-1 virion antigens without viral replication. Nature Medicine, 7(3), 344–349.

Authors 9
  1. Florence Buseyne (first)
  2. Sylvie Le Gall (additional)
  3. Claire Boccaccio (additional)
  4. Jean-Pierre Abastado (additional)
  5. Jeffrey D. Lifson (additional)
  6. Larry O. Arthur (additional)
  7. Yves Rivière (additional)
  8. Jean-Michel Heard (additional)
  9. Olivier Schwartz (additional)
References 45 Referenced 130
  1. Rock, K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17, 129–137 (1996). (10.1016/0167-5699(96)80605-0) / Immunol. Today by KL Rock (1996)
  2. Jondal, M., Schirmbeck, R. & Reimann, J. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295–302 (1996). (10.1016/S1074-7613(00)80255-1) / Immunity by M Jondal (1996)
  3. Yewdell, J.W., Norbury, C.C., Bennink, J.R. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: Implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv. Immunol. 73, 1–77 (1999). (10.1016/S0065-2776(08)60785-3) / Adv. Immunol. by JW Yewdell (1999)
  4. Lanzavecchia, A. Mechanisms of antigen uptake for presentation. Curr. Op. Immunol. 8, 348–354 (1996). (10.1016/S0952-7915(96)80124-5) / Curr. Op. Immunol. by A Lanzavecchia (1996)
  5. Watts, C. Capture and processing of exogenous antigens for presentation on MHC molecules. Ann. Rev. Immunol. 15, 821–850 (1997). (10.1146/annurev.immunol.15.1.821) / Ann. Rev. Immunol. by C Watts (1997)
  6. Kovacsovics-Bankowski, M. & Rock, K.L. A phagosome to cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267, 243–246 (1995). (10.1126/science.7809629) / Science by M Kovacsovics-Bankowski (1995)
  7. Singh-Jasuja, H. et al. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 191, 1965–1974 (2000). (10.1084/jem.191.11.1965) / J. Exp. Med. by H Singh-Jasuja (2000)
  8. Castellino, F. et al. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class 1 antigen presentation via two distinct processing pathways. J. Exp. Med. 191, 1957–1964 (2000). (10.1084/jem.191.11.1957) / J. Exp. Med. by F Castellino (2000)
  9. Regnault, A. et al. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189, 371–380 (1999). (10.1084/jem.189.2.371) / J. Exp. Med. by A Regnault (1999)
  10. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P. & Amigorena, S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nature Cell Biol. 1, 362–368 (1999). (10.1038/14058) / Nature Cell Biol. by A Rodriguez (1999)
  11. Gromme, M. et al. Recycling MHC class I molecules and endosomal peptide loading. Proc. Nat. Acad. Sci. USA 96, 10326–10331 (1999). (10.1073/pnas.96.18.10326) / Proc. Nat. Acad. Sci. USA by M Gromme (1999)
  12. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245–252 (1998). (10.1038/32588) / Nature by J Banchereau (1998)
  13. Albert, M.L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392, 86–89 (1998). (10.1038/32183) / Nature by ML Albert (1998)
  14. Sigal, L.J., Crotty, S., Andino, R. & Rock, K.L. Cytotoxic T-cell immunity to virus-infected non-hematopoietic cells requires presentation of exogenous antigen. Nature 398, 77–80 (1999). (10.1038/18038) / Nature by LJ Sigal (1999)
  15. Yewdell, J.W., Bennink, J.R. & Hosaka, Y. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239, 637–640 (1988). (10.1126/science.3257585) / Science by JW Yewdell (1988)
  16. Reimann, J. & Schirmbeck, R. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation. Immunol. Rev. 172, 131–152 (1999). (10.1111/j.1600-065X.1999.tb01362.x) / Immunol. Rev. by J Reimann (1999)
  17. Cameron, P., Pope, M., Granelli-Piperno, A. & Steinman, R.M. Dendritic cells and the replication of HIV-1. J. Leuk. Biol. 59, 158–171 (1996). (10.1002/jlb.59.2.158) / J. Leuk. Biol. by P Cameron (1996)
  18. Knight, S.C. & Patterson, S. Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology. Annu. Rev. Immunol. 15, 593–615 (1997). (10.1146/annurev.immunol.15.1.593) / Annu. Rev. Immunol. by SC Knight (1997)
  19. Granelli-Piperno, A. et al. Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J. Exp. Med. 184, 2433–2438 (1996). (10.1084/jem.184.6.2433) / J. Exp. Med. by A Granelli-Piperno (1996)
  20. Ayehunie, S. et al. Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors. Blood 90, 1379–1386 (1997). (10.1182/blood.V90.4.1379) / Blood by S Ayehunie (1997)
  21. Klagge, I.M. & Schneider-Schaulies, S. Virus interactions with dendritic cells. J. Gen. Virol. 80, 823–833 (1999). (10.1099/0022-1317-80-4-823) / J. Gen. Virol. by IM Klagge (1999)
  22. Granelli-Piperno, A., Finkel, V., Delgado, E. & Steinman, R.M. Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells. Curr. Biol. 9, 21–29 (1999). (10.1016/S0960-9822(99)80043-8) / Curr. Biol. by A Granelli-Piperno (1999)
  23. Geijtenbeek, T.B. et al. DC-SIGN, a dendritic cell-specific HIV-1–binding protein that enhances trans-infection of T cells. Cell 100, 587–597 (2000). (10.1016/S0092-8674(00)80694-7) / Cell by TB Geijtenbeek (2000)
  24. Lapham, C.K., Zaitseva, M.B., Lee, S., Romanstseva, T. & Golding, H. Fusion of monocytes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nature Med. 5, 303–308 (1999). (10.1038/6523) / Nature Med. by CK Lapham (1999)
  25. Aiken, C. Pseudotyping HIV-1 by the glycoprotein of VSV targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71, 5871–5877 (1997). (10.1128/JVI.71.8.5871-5877.1997) / J. Virol. by C Aiken (1997)
  26. Yang, O.O. et al. Efficient lysis of Human Immunodeficiency Virus type 1-infected cells by cytotoxic T lymphocytes. J. Virol. 70, 5799–5806 (1996). (10.1128/JVI.70.9.5799-5806.1996) / J. Virol. by OO Yang (1996)
  27. Naldini, L. et al. In vivo gene delivery and stable transduction of non dividing cells by a lentiviral vector. Science 272, 263–267 (1996). (10.1126/science.272.5259.263) / Science by L Naldini (1996)
  28. Rossio, J.L. et al. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J. Virol. 72, 7992–8001 (1998). (10.1128/JVI.72.10.7992-8001.1998) / J. Virol. by JL Rossio (1998)
  29. Arthur, L.O. et al. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. AIDS Res. Hum. Retrov. 14, s311–s319 (1998). (10.1089/aid.1998.14.311) / AIDS Res. Hum. Retrov. by LO Arthur (1998)
  30. Bergeron, L., Sullivan, N. & Sodroski, J. Target cell-specific determinants of membrane fusion within the Human Immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus. J. Virol. 66, 2389–2397 (1992). (10.1128/JVI.66.4.2389-2397.1992) / J. Virol. by L Bergeron (1992)
  31. Whitt, M.A., Zagouras, P., Crise, B. & Rose, J.K. A fusion-defective mutant of the Vesicular Stomatitis Virus glycoprotein. J. Virol. 64, 4907–4913 (1990). (10.1128/JVI.64.10.4907-4913.1990) / J. Virol. by MA Whitt (1990)
  32. Buseyne, F., Février, M., Garcia, S., Gougeon, M.L. & Rivière, Y. Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells. Virology 225, 248–253 (1996). (10.1006/viro.1996.0597) / Virology by F Buseyne (1996)
  33. Piatak, M., Jr . et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749–1754 (1993). (10.1126/science.8096089) / Science by M Piatak Jr (1993)
  34. Embreston, J. et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359–362 (1993). (10.1038/362359a0) / Nature by J Embreston (1993)
  35. Schwartz, O., Marechal, V., Friguet, B., Arenzana-Seisdedos, F. & Heard, J.M. Antiviral activity of the proteasome on incoming HIV-1. J. Virol. 72, 3845–3850 (1998). (10.1128/JVI.72.5.3845-3850.1998) / J. Virol. by O Schwartz (1998)
  36. Schwartz, O., Maréchal, V., Le Gall, S., Lemonnier, F. & Heard, J.M. Endocytosis of MHC-I molecules is induced by HIV-1 Nef. Nature Med. 2, 338–342 (1996). (10.1038/nm0396-338) / Nature Med. by O Schwartz (1996)
  37. Collins, K.L., Chen, B.K., Kalams, S.A., Walker, B.D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397–401 (1998). (10.1038/34929) / Nature by KL Collins (1998)
  38. Pinto, L.A. et al. Env-specific cytotoxic T lymphocytes responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J. Clin. Invest. 96, 867–876 (1995). (10.1172/JCI118133) / J. Clin. Invest. by LA Pinto (1995)
  39. Rowland-Jones, S. et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1, 59–64 (1995). (10.1038/nm0195-59) / Nature Med. by S Rowland-Jones (1995)
  40. Rowland-Jones, S., Tan, R. & McMichael, A. Role of cellular immunity in protection against HIV infection. Adv. Immunol. 65, 277–346 (1997). (10.1016/S0065-2776(08)60745-2) / Adv. Immunol. by S Rowland-Jones (1997)
  41. Brander, C. & Walker, B.D. T lymphocyte responses in HIV-1 infection: implications for vaccine development. Curr. Op. Immunol. 11, 451–459 (1999). (10.1016/S0952-7915(99)80076-4) / Curr. Op. Immunol. by C Brander (1999)
  42. Goxe, B., Latour, N., Bartholeyns, J., Romet-Lemonne, J.L. & Chokri, M. Monocyte-derived dendritic cells: development of a cellular processor for clinical applications. Res. Immunol. 149, 643–646 (1998). (10.1016/S0923-2494(99)80031-5) / Res. Immunol. by B Goxe (1998)
  43. Buseyne, F. et al. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children. Virology 250, 316–324 (1998). (10.1006/viro.1998.9373) / Virology by F Buseyne (1998)
  44. Tsomides, T.J. et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by Human Immunodeficiency Virus type 1. J. Exp. Med. 180, 1283–1293 (1994). (10.1084/jem.180.4.1283) / J. Exp. Med. by TJ Tsomides (1994)
  45. Czerkinsky, C. et al. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Meth. 110, 29–36 (1988). (10.1016/0022-1759(88)90079-8) / J. Immunol. Meth. by C Czerkinsky (1988)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:48 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:04 p.m.)
Indexed 5 months ago (March 29, 2025, 12:12 p.m.)
Issued 24 years, 5 months ago (March 1, 2001)
Published 24 years, 5 months ago (March 1, 2001)
Published Print 24 years, 5 months ago (March 1, 2001)
Funders 0

None

@article{Buseyne_2001, title={MHC-I–restricted presentation of HIV-1 virion antigens without viral replication}, volume={7}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/85493}, DOI={10.1038/85493}, number={3}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Buseyne, Florence and Gall, Sylvie Le and Boccaccio, Claire and Abastado, Jean-Pierre and Lifson, Jeffrey D. and Arthur, Larry O. and Rivière, Yves and Heard, Jean-Michel and Schwartz, Olivier}, year={2001}, month=mar, pages={344–349} }